Skip to main content
TNDM
NASDAQ Industrial Applications And Services

Shareholders to Vote on Significant Equity Plan Increase and Officer Liability Limits

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$21
Mkt Cap
$1.435B
52W Low
$9.98
52W High
$29.65
52W Position info
110% above low
Off High info
29% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

TNDM has more than doubled off its 52-week low of $9.98.

Summary

Tandem Diabetes Care is asking shareholders to approve a 3.26 million share increase for its equity incentive plan, representing a potential 4.76% dilution, and an amendment to limit officer liability.


Key Events · Corporate Governance and Compliance · TNDM

  • Proposal to Increase Equity Plan Shares

    Shareholders will vote on increasing the shares authorized for the 2023 Long-Term Incentive Plan by 3,260,000 shares. This represents a potential dilution of approximately 4.76% if all authorized shares were issued, which is a substantial amount.

  • Vote on Officer Liability Exculpation

    The company proposes an amendment to its Certificate of Incorporation to limit the personal liability of officers to the maximum extent permitted by Delaware law. This aims to attract and retain officers but may be seen as reducing accountability.

  • Annual Meeting Agenda Set

    The preliminary proxy statement outlines the agenda for the May 20, 2026, Annual Meeting, including the routine election of nine directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2026.


Analysis · TNDM · Industrial Applications And Services

Tandem Diabetes Care is seeking shareholder approval for several key proposals at its upcoming annual meeting. The most significant is the request to increase the number of shares authorized for issuance under its 2023 Long-Term Incentive Plan by 3,260,000 shares. If all these shares were issued, it would result in a potential dilution of approximately 4.76% based on the current outstanding shares. This substantial potential dilution could impact existing shareholder value. Additionally, the company proposes an amendment to its Certificate of Incorporation to limit the personal liability of officers, which is a governance change that could be viewed negatively by some investors as it reduces accountability, though it aims to attract and retain talent. Other proposals, such as the election of directors and ratification of the auditor, are routine.

At the time of this filing, TNDM was trading at $21.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $9.98 to $29.65. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TNDM - Latest Insights

TNDM
May 21, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.76
Real-time Price: $17.78 info
Change: +$2.02 (+13%) info
Market Cap: $1.217B info
TNDM
May 15, 2026, 7:59 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.03
Real-time Price: $17.78 info
Change: +$3.75 (+27%) info
Market Cap: $1.217B info
TNDM
May 07, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $20.86
Real-time Price: $17.78 info
Change: -$3.08 (-15%) info
Market Cap: $1.217B info
TNDM
May 07, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.04
Real-time Price: $17.78 info
Change: -$2.26 (-11%) info
Market Cap: $1.217B info
TNDM
Apr 27, 2026, 9:21 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $20.75
Real-time Price: $17.78 info
Change: -$2.97 (-14%) info
Market Cap: $1.217B info